Ossiform® – New market-oriented Chairman of the Board

Ossiform® – New market-oriented Chairman of the Board

Ossiform® – New market-oriented Chairman of the Board

ODENSE, 1st June 2021 – Ossiform®, We Print Bone™, is pleased to announce that a new and highly qualified Chairman of the Board has been found.
The Company appoints Mette-Marie Harild as new Chairman of the Board if she is elected to the board of directors at Ossiform® Limited’s general meeting which will take place on 15th June 2021.

“It is important for Ossiform® to strengthen its competences in the sales and marketing of implants, including in devising market launch strategies for new product introductions and identifying new opportunities for strategic partnering. The board plays an essential role in these important endeavours, and therefore, I am very pleased that Mette-Marie has accepted taking the position as Chairman. With her large network and many years of experience from the medtech industry, Mette-Marie is just the right person to help secure a successful introduction of P3D Bone and support our company’s international expansion.”, says CEO, Thea Wulff Olesen.

Mette-Marie Harild has extensive experience from the pharma/medtech industry, most recently from one of the world’s leading medical device companies, Medtronic, where Mette-Marie has been employed for many years. Most recently, she served as Regional Vice President ABGI & Nordic. Mette-Marie is a trained dentist and holds an MBA in change management. Mette-Marie also holds positions as director in Neurescue, QLife and Occlutech. Previously, she served as Chairman of the board in AmCham Healthcare Committee along with several other board- and committee roles.

Mette-Marie Harild likewise looks forward to the collaboration on developing Ossiform®’s disruptive technology and commercializing the unique products. She adds, ”The 3D printed and patient specific bone implants from Ossiform® are highly innovative and the P3D Bone will cover a vast market need as well as generate value for patients worldwide. I am looking forward to contribute to finalising the product development and launch the P3D Bone in cooperation with the entire team.”

Ossiform® is a Danish MedTech company founded on proprietary technology to 3D print patient specific, natural, and resorbable bone implants. The enables fast ingrowth of bone tissue, remodeling into real living bone, and results in fewer complications. The technology is further used to provide 3D printed R&D products for enhancing bone research, develop implants with additives, such as antibiotics or other drugs, and even has applications in industries outside healthcare. Website: Ossiform® – We Print Bone

For more information, please contact:


Thea Wulff Olesen, CEO

Tel.: +45 26 32 63 32

Mette-Marie Harild

Tel.: +45 51 99 08 18